Frankincense, specifically the extract from the Boswellia serrata tree, does show real promise for joint pain relief. Multiple placebo-controlled trials have found it significantly reduces both pain and stiffness in people with knee osteoarthritis, and its active compounds work through a specific anti-inflammatory pathway that’s well understood. It’s not a miracle cure, but the evidence is stronger than for most herbal supplements.
How Frankincense Reduces Inflammation
The resin of the Boswellia serrata tree contains a group of active compounds called boswellic acids. The most potent of these works by directly blocking an enzyme called 5-lipoxygenase, which your body uses to produce inflammatory molecules called leukotrienes. Leukotrienes drive swelling, pain, and stiffness in your joints, so shutting down their production at the source is a meaningful way to reduce symptoms.
This mechanism is distinct from how common over-the-counter painkillers work. Ibuprofen and similar drugs block a different set of inflammatory pathways (the COX enzymes), which is why they carry risks of stomach bleeding and kidney problems with long-term use. Frankincense targets a separate branch of the inflammation cascade, which may explain why it appears gentler on the gut and kidneys in safety studies.
What the Clinical Trials Show
The best evidence comes from double-blind, placebo-controlled studies in people with knee osteoarthritis. In two trials of 60 patients each, an enriched Boswellia extract taken daily produced significant improvements in pain and stiffness compared to placebo. In the first study, after 30 days of treatment, pain scores dropped by 23.6 points in the Boswellia group versus just 5.6 points with placebo. Stiffness scores showed a similar gap: an 18.8-point improvement versus 3.4 with placebo.
The longer people took it, the better the results got. In the second 90-day trial, pain scores improved by 31.1 points (compared to 8.4 with placebo) and stiffness by 27.7 points (compared to 9.9). These are clinically meaningful differences, not just statistical ones. Participants reported noticeably easier movement and less discomfort during everyday activities like walking and climbing stairs.
A systematic review and meta-analysis looking across multiple Boswellia trials for osteoarthritis confirmed the overall trend: the extract consistently outperformed placebo for pain and physical function. Safety data from animal toxicity studies and human trials found no toxic effects, making it a reasonable option for people who can’t tolerate standard anti-inflammatory drugs due to stomach, kidney, or cardiovascular issues.
How Quickly It Works
Don’t expect overnight results. Most clinical trials show meaningful improvements emerging after about 7 to 10 days of consistent use, with benefits continuing to build over weeks. In one study on exercise-induced soreness and knee pain, participants taking a standardized Boswellia extract had significantly lower knee soreness scores by day 8, and by day 10 their soreness while squatting and descending stairs was markedly lower than the placebo group. At 72 hours after intense exercise, soreness was roughly 50% lower in the supplement group.
For osteoarthritis specifically, the 30-day and 90-day trial data suggest that while you may notice initial relief within the first two weeks, the full benefit takes one to three months to develop. This is a supplement you need to take consistently, not one you pop when pain flares up.
Dosage and What to Look For
Clinical trials have safely used Boswellia serrata extract in doses up to 1,000 mg daily for periods up to six months, according to the National Institutes of Health. Higher doses of 2,400 mg daily have been used safely for shorter periods of up to one month. The enriched formulations that produced the strongest results in osteoarthritis trials used a concentrated extract at just 100 mg per day, but these were standardized to contain a high percentage of the key active compound (acetyl-11-keto-beta-boswellic acid, often listed as AKBA on supplement labels).
This is where supplement shopping gets tricky. Not all Boswellia products are created equal. A generic frankincense capsule with unstandardized resin powder will contain far less of the active compound than an extract specifically enriched for AKBA. When choosing a product, look for one that lists the percentage of boswellic acids or AKBA on the label. The clinical trials producing the best results used extracts specifically designed to concentrate these compounds.
Topical Frankincense Oil: Limited Evidence
Frankincense essential oil is widely sold for topical use, but there’s an important distinction between rubbing oil on your skin and taking an oral extract. The active boswellic acids are large, fat-soluble molecules that don’t easily pass through the skin barrier to reach joint tissue underneath. Research on frankincense oil’s skin penetration has actually focused on formulating it into specialized nanoparticles specifically because the unformulated oil doesn’t absorb well on its own.
If you enjoy the sensation of massaging frankincense oil into sore joints, the massage itself may provide some temporary relief. But the strong clinical evidence for pain and stiffness reduction comes from oral supplements, not topical application. There are currently no rigorous human trials showing that frankincense essential oil applied to the skin delivers enough active compound to meaningfully reduce joint inflammation.
Osteoarthritis vs. Rheumatoid Arthritis
Nearly all of the well-designed clinical trials have focused on osteoarthritis, the wear-and-tear form of joint disease. The evidence for Boswellia in rheumatoid arthritis, an autoimmune condition, is much thinner. Because the 5-lipoxygenase pathway does play a role in autoimmune inflammation, there’s biological reason to think it could help, but the clinical proof isn’t there yet in the same way it is for osteoarthritis.
If you have rheumatoid arthritis, Boswellia shouldn’t replace prescribed disease-modifying treatments. It might serve as a complementary option for symptom management, but that’s a conversation worth having with your rheumatologist given the different nature of the disease.
Safety and Drug Interactions
Boswellia has a favorable safety profile in studies lasting up to six months. Unlike ibuprofen and similar drugs, it has not been associated with stomach ulcers, gastrointestinal bleeding, or kidney damage in clinical trials. Reported side effects in studies were rare and mild, with no statistically significant difference between the supplement and placebo groups.
There are two notable cautions. First, if you take blood-thinning medications like warfarin, Boswellia may amplify their effect. Two case reports documented elevated blood-clotting times in warfarin patients, likely because the extract interferes with certain liver enzymes that process the drug. Second, people taking immunosuppressive medications (commonly prescribed after organ transplants or for autoimmune conditions) should be cautious, as Boswellia may alter how those drugs are metabolized. If you’re on either type of medication, it’s worth checking with your prescriber before adding Boswellia to your routine.